• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Discovery of allosteric modulators of factor XIa by targeting hydrophobic domains adjacent to its heparin-binding site.通过靶向因子 XIa 肝素结合位点相邻的疏水结构域发现别构调节剂。
J Med Chem. 2013 Mar 28;56(6):2415-28. doi: 10.1021/jm301757v. Epub 2013 Mar 18.
2
Studies on fragment-based design of allosteric inhibitors of human factor XIa.人凝血因子XIa变构抑制剂的基于片段设计的研究
Bioorg Med Chem. 2020 Dec 1;28(23):115762. doi: 10.1016/j.bmc.2020.115762. Epub 2020 Sep 13.
3
Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitor.凝血因子XIa催化结构域上肝素结合位点的表征:丝氨酸蛋白酶抑制剂抗凝血酶和C1抑制剂对肝素加速凝血因子XIa抑制作用的机制
Biochemistry. 2009 Feb 24;48(7):1517-24. doi: 10.1021/bi802298r.
4
Allosteric inhibition of human factor XIa: discovery of monosulfated benzofurans as a class of promising inhibitors.变构抑制人凝血因子 XIa:单磺酸苯并呋喃类化合物作为一类有前景的抑制剂的发现。
J Med Chem. 2014 Apr 24;57(8):3559-69. doi: 10.1021/jm5002698. Epub 2014 Apr 7.
5
Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides.设计因子 XIa 的别构抑制剂。硫酸五没食子酰葡萄糖吡喃糖苷相互作用的启示。
J Med Chem. 2014 Jun 12;57(11):4805-18. doi: 10.1021/jm500311e. Epub 2014 May 29.
6
Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants.凝血因子XIa的变构抑制。硫酸化非糖类糖胺聚糖模拟物作为有前景的抗凝剂。
Thromb Res. 2015 Aug;136(2):379-87. doi: 10.1016/j.thromres.2015.04.017. Epub 2015 Apr 22.
7
Sulfonated non-saccharide molecules and human factor XIa: Enzyme inhibition and computational studies.磺化非糖分子与人类因子 XIa:酶抑制和计算研究。
Chem Biol Drug Des. 2022 Jul;100(1):64-79. doi: 10.1111/cbdd.14053. Epub 2022 Apr 11.
8
A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding.一种合成的肝素类似物,通过变构抑制因子 XIa,并减少体内血栓形成,而不会增加出血风险。
J Thromb Haemost. 2019 Dec;17(12):2110-2122. doi: 10.1111/jth.14606. Epub 2019 Sep 10.
9
Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa.硫酸五没食子酰葡萄糖苷是一种强效的、变构的、选择性因子 XIa 抑制剂。
J Med Chem. 2013 Feb 14;56(3):867-78. doi: 10.1021/jm301338q. Epub 2013 Jan 28.
10
Discovery of Benzyl Tetraphosphonate Derivative as Inhibitor of Human Factor Xia.发现苯甲基四膦酸衍生物作为人因子 Xia 的抑制剂。
ChemistryOpen. 2020 Nov 10;9(11):1161-1172. doi: 10.1002/open.202000277. eCollection 2020 Nov.

引用本文的文献

1
Synthesis and Evaluation of 2‑Substituted Quinazolin-4(3)‑ones as Potential Antileukemic Agents.2-取代喹唑啉-4(3)-酮作为潜在抗白血病药物的合成与评价
ACS Omega. 2025 Aug 1;10(31):34882-34894. doi: 10.1021/acsomega.5c04106. eCollection 2025 Aug 12.
2
Investigation of the anticoagulant activity of cyclic sulfated glycosaminoglycan mimetics.环状硫酸化糖胺聚糖类似物抗凝活性的研究。
Carbohydr Res. 2023 Jul;529:108831. doi: 10.1016/j.carres.2023.108831. Epub 2023 May 4.
3
Designing Smaller, Synthetic, Functional Mimetics of Sulfated Glycosaminoglycans as Allosteric Modulators of Coagulation Factors.设计更小的、合成的、功能性的硫酸化糖胺聚糖类似物作为凝血因子的别构调节剂。
J Med Chem. 2023 Apr 13;66(7):4503-4531. doi: 10.1021/acs.jmedchem.3c00132. Epub 2023 Mar 31.
4
Factor XI, a potential target for anticoagulation therapy for venous thromboembolism.凝血因子XI,静脉血栓栓塞抗凝治疗的潜在靶点。
Front Cardiovasc Med. 2022 Oct 31;9:975767. doi: 10.3389/fcvm.2022.975767. eCollection 2022.
5
Studies on fragment-based design of allosteric inhibitors of human factor XIa.人凝血因子XIa变构抑制剂的基于片段设计的研究
Bioorg Med Chem. 2020 Dec 1;28(23):115762. doi: 10.1016/j.bmc.2020.115762. Epub 2020 Sep 13.
6
A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding.一种合成的肝素类似物,通过变构抑制因子 XIa,并减少体内血栓形成,而不会增加出血风险。
J Thromb Haemost. 2019 Dec;17(12):2110-2122. doi: 10.1111/jth.14606. Epub 2019 Sep 10.
7
Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies.硫酸化非糖基化糖胺聚糖类似物作为用于各种病理的新型药物发现平台。
Curr Med Chem. 2020;27(21):3412-3447. doi: 10.2174/0929867325666181120101147.
8
Inhibition of Herpes Simplex Virus-1 Entry into Human Cells by Nonsaccharide Glycosaminoglycan Mimetics.非糖类糖胺聚糖模拟物对单纯疱疹病毒1型进入人细胞的抑制作用
ACS Med Chem Lett. 2018 Jul 16;9(8):797-802. doi: 10.1021/acsmedchemlett.7b00364. eCollection 2018 Aug 9.
9
Recent advances in the discovery and development of factor XI/XIa inhibitors.近年来,因子 XI/XIa 抑制剂的发现和开发取得了新进展。
Med Res Rev. 2018 Sep;38(6):1974-2023. doi: 10.1002/med.21503. Epub 2018 May 4.
10
A molecular dynamics-based algorithm for evaluating the glycosaminoglycan mimicking potential of synthetic, homogenous, sulfated small molecules.一种基于分子动力学的算法,用于评估合成的、同质的、硫酸化小分子模拟糖胺聚糖的潜力。
PLoS One. 2017 Feb 9;12(2):e0171619. doi: 10.1371/journal.pone.0171619. eCollection 2017.

本文引用的文献

1
Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa.硫酸五没食子酰葡萄糖苷是一种强效的、变构的、选择性因子 XIa 抑制剂。
J Med Chem. 2013 Feb 14;56(3):867-78. doi: 10.1021/jm301338q. Epub 2013 Jan 28.
2
On the specificity of heparin/heparan sulfate binding to proteins. Anion-binding sites on antithrombin and thrombin are fundamentally different.肝素/硫酸乙酰肝素与蛋白质特异性结合的研究。抗凝血酶和凝血酶的阴离子结合位点在本质上是不同的。
PLoS One. 2012;7(11):e48632. doi: 10.1371/journal.pone.0048632. Epub 2012 Nov 12.
3
Designing allosteric regulators of thrombin. Monosulfated benzofuran dimers selectively interact with Arg173 of exosite 2 to induce inhibition.设计凝血酶的别构调节剂。单磺酸化苯并呋喃二聚体选择性地与外位 2 的 Arg173 相互作用,诱导抑制。
J Med Chem. 2012 Aug 9;55(15):6888-97. doi: 10.1021/jm300670q. Epub 2012 Jul 25.
4
Sulfated, low molecular weight lignins inhibit a select group of heparin-binding serine proteases.硫酸化、低分子量木质素抑制了一组特定的肝素结合丝氨酸蛋白酶。
Biochem Biophys Res Commun. 2012 Jan 6;417(1):382-6. doi: 10.1016/j.bbrc.2011.11.122. Epub 2011 Dec 1.
5
Identification of the site of binding of sulfated, low molecular weight lignins on thrombin.鉴定硫酸化、低分子量木质素在凝血酶上的结合部位。
Biochem Biophys Res Commun. 2011 Sep 23;413(2):348-52. doi: 10.1016/j.bbrc.2011.08.102. Epub 2011 Aug 27.
6
Designing nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa.设计非糖基、变构的抗凝血酶激活剂,以加速对因子 Xa 的抑制。
J Med Chem. 2011 Sep 8;54(17):6125-38. doi: 10.1021/jm2008387. Epub 2011 Aug 12.
7
Polysulfated xanthones: multipathway development of a new generation of dual anticoagulant/antiplatelet agents.多硫酸化木酮素:新一代双重抗凝/抗血小板药物的多途径研发。
J Med Chem. 2011 Aug 11;54(15):5373-84. doi: 10.1021/jm2006589. Epub 2011 Jul 18.
8
Rational design of potent, small, synthetic allosteric inhibitors of thrombin.合理设计强效、小尺寸、合成变构凝血酶抑制剂。
J Med Chem. 2011 Aug 11;54(15):5522-31. doi: 10.1021/jm2005767. Epub 2011 Jul 18.
9
Heparan sulfate proteoglycans.肝素硫酸蛋白聚糖。
Cold Spring Harb Perspect Biol. 2011 Jul 1;3(7):a004952. doi: 10.1101/cshperspect.a004952.
10
A small-molecule factor XIa inhibitor produces antithrombotic efficacy with minimal bleeding time prolongation in rabbits.小分子因子 XIa 抑制剂可产生抗血栓作用,同时最小化延长兔子的出血时间。
J Thromb Thrombolysis. 2011 Aug;32(2):129-37. doi: 10.1007/s11239-011-0599-0.

通过靶向因子 XIa 肝素结合位点相邻的疏水结构域发现别构调节剂。

Discovery of allosteric modulators of factor XIa by targeting hydrophobic domains adjacent to its heparin-binding site.

机构信息

Department of Medicinal Chemistry and Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond, Virginia 23298, USA.

出版信息

J Med Chem. 2013 Mar 28;56(6):2415-28. doi: 10.1021/jm301757v. Epub 2013 Mar 18.

DOI:10.1021/jm301757v
PMID:23451707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3625964/
Abstract

To discover promising sulfated allosteric modulators (SAMs) of glycosaminoglycan-binding proteins (GBPs), such as human factor XIa (FXIa), we screened a library of 26 synthetic, sulfated quinazolin-4(3H)-ones (QAOs) resulting in the identification of six molecules that reduced the Vmax of substrate hydrolysis without influencing the KM. Mutagenesis of residues of the heparin-binding site (HBS) of FXIa introduced a nearly 5-fold loss in inhibition potency supporting recognition of an allosteric site. Fluorescence studies showed a sigmoidal binding profile indicating highly cooperative binding. Competition with a positively charged, heparin-binding polymer did not fully nullify inhibition suggesting importance of hydrophobic forces to binding. This discovery suggests the operation of a dual-element recognition process, which relies on an initial Coulombic attraction of anionic SAMs to the cationic HBS of FXIa that forms a locked complex through tight interaction with an adjacent hydrophobic patch. The dual-element strategy may be widely applicable for discovering SAMs of other GBPs.

摘要

为了发现有前景的糖胺聚糖结合蛋白 (GBPs) 的硫酸化变构调节剂 (SAM),例如人凝血因子 XIa (FXIa),我们筛选了 26 种合成的磺化喹唑啉-4(3H)-酮 (QAO) 文库,结果鉴定出了 6 种分子,它们在不影响 KM 的情况下降低了底物水解的 Vmax。FXIa 肝素结合位点 (HBS) 残基的突变导致抑制效力降低近 5 倍,支持变构结合位点的识别。荧光研究显示出明显的 S 型结合曲线,表明高度协同的结合。与带正电荷的肝素结合聚合物的竞争并未完全消除抑制作用,这表明疏水作用力对结合很重要。这一发现表明存在双元件识别过程,该过程依赖于阴离子 SAM 与 FXIa 的阳离子 HBS 的初始库仑吸引力,该吸引力通过与相邻的疏水性斑块的紧密相互作用形成锁定复合物。双元件策略可能广泛适用于发现其他 GBPs 的 SAM。